Search
for
Sort by
Research 631–660 of 1000+
- Medicinal and cosmetic products used in treatment of hair loss
- Polycystic ovary syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Budesonide for maintenance of remission in Crohn's disease
- Development and homeostasis of the sebaceous gland
- Advances in the human skin microbiota and its roles in cutaneous diseases
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Safety of testosterone treatment in postmenopausal women
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Insulin Resistance and Skin Diseases
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Endogenous retinoids in the hair follicle and sebaceous gland
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- An Update on Plant Derived Anti-Androgens
- Common Skin Disorders in Pediatric Skin of Color
- Transgender health and the impact of aging and menopause
- Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Colchicine in Managing Skin Conditions: A Systematic Review
- Dermatologic Conditions in Transgender Populations
- Dermatological problems of the puberty
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Alopecia areata: Part 2: treatment.
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Metabolic syndrome and dermatological diseases: association and treatment